Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $36.5550 (-7.03%) ($36.5550 - $36.5550) on Thu. Feb. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.52% (three month average) | RSI | 23 | Latest Price | $36.5550(-7.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -4.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -9.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(47%) XBI(44%) ARKG(43%) IWO(41%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.76% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.76% (StdDev 3.52%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $26.55(-27.37%) | Inflection Point | Yes | Resistance Level | $45.79 | 5 Day Moving Average | $41.28(-11.45%) | 10 Day Moving Average | $44.04(-17%) | 20 Day Moving Average | $45.79(-20.17%) | To recent high | -30.5% | To recent low | 0% | Market Cap | $5.353b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |